#1 Clinical Trials Search in Europe

Finasteride

This article examines clinical trials investigating the drug Finasteride, a medication primarily used to treat male pattern baldness and benign prostatic hyperplasia. The trials explore various aspects of Finasteride, including its bioequivalence to other formulations, its efficacy in treating different conditions, and its safety profile. These studies provide valuable insights into the drug’s potential applications and effects on patients.

Table of Contents

What is Finasteride?

Finasteride is a medication that belongs to a class of drugs called 5-alpha reductase inhibitors. It is marketed under various brand names, including Propecia and Proscar[1][2]. Finasteride is primarily used to treat conditions related to male hormones, particularly those affecting the prostate gland and hair growth.

Uses of Finasteride

Finasteride is approved by the FDA for several uses:

  • Benign Prostatic Hyperplasia (BPH): This is a condition where the prostate gland becomes enlarged, causing urinary symptoms. Finasteride, particularly in its 5 mg form (often sold as Proscar), is used to treat BPH and reduce the risk of needing surgery[3].
  • Male Pattern Baldness: Also known as androgenetic alopecia, this is a common form of hair loss in men. Finasteride, in its 1 mg form (often sold as Propecia), is used to treat this condition[4].
  • Prostate Cancer Prevention: Some studies suggest that finasteride may help reduce the risk of prostate cancer, although this is not its primary use[5].

How Finasteride Works

Finasteride works by inhibiting an enzyme called 5-alpha reductase. This enzyme is responsible for converting testosterone (a male hormone) into dihydrotestosterone (DHT). DHT is a more potent form of testosterone that contributes to prostate enlargement and male pattern baldness[6].

By reducing the amount of DHT in the body, finasteride can:

  • Slow down or stop the growth of the prostate gland
  • Reduce hair loss and potentially promote hair regrowth in men with male pattern baldness

Dosage and Administration

The dosage of finasteride depends on the condition being treated:

  • For BPH: The typical dose is 5 mg taken orally once daily[7].
  • For male pattern baldness: The typical dose is 1 mg taken orally once daily[8].

Finasteride is usually taken as a tablet with or without food. It’s important to take it regularly as prescribed by your doctor for the best results.

Side Effects

Like all medications, finasteride can cause side effects, although not everyone experiences them. Some potential side effects include:

  • Decreased sexual desire
  • Difficulty getting or maintaining an erection
  • Decreased amount of semen released during sex
  • Depression
  • Breast tenderness or enlargement

It’s important to discuss any side effects with your healthcare provider. They can help determine if the benefits of the medication outweigh the risks for your specific situation[9].

Ongoing Research

Researchers continue to study finasteride for potential new uses and to better understand its effects. Some areas of ongoing research include:

  • Central Serous Chorioretinopathy (CSC): This is an eye condition where fluid accumulates under the retina. Some studies are investigating whether finasteride could be a potential treatment for chronic CSC[10].
  • Testosterone-Induced Erythrocytosis: This is a condition where there’s an increase in red blood cells due to testosterone therapy. Researchers are studying whether finasteride could help manage this side effect[7].
  • New Formulations: Scientists are exploring new ways to deliver finasteride, such as topical applications, which might reduce systemic side effects[5].

It’s important to note that these are areas of ongoing research, and finasteride is not currently approved for these uses. Always consult with your healthcare provider about the most appropriate treatments for your specific condition.

Aspect Details
Primary Uses of Finasteride Treatment of male pattern baldness and benign prostatic hyperplasia
Dosages Studied 1 mg, 3 mg, and 5 mg tablets
Conditions Explored Androgenetic alopecia, benign prostatic hyperplasia, central serous chorioretinopathy, testosterone-induced erythrocytosis
Study Designs Bioequivalence studies, randomized controlled trials, crossover studies
Duration of Trials Ranging from single-dose studies to long-term trials lasting up to 5 years
Key Outcome Measures Bioequivalence parameters, changes in hair count and thickness, visual acuity, serum hormone levels, subretinal fluid volume
Safety Monitoring Adverse events, changes in hormone levels, effects on blood parameters
Novel Applications Potential use in treating central serous chorioretinopathy and managing testosterone-induced erythrocytosis

FAQ

  • What is Finasteride used for? Finasteride is primarily used to treat male pattern baldness (androgenetic alopecia) and benign prostatic hyperplasia (enlarged prostate). Some trials are also exploring its potential use in treating other conditions like central serous chorioretinopathy and managing testosterone-induced erythrocytosis.
  • How does Finasteride work? Finasteride works by inhibiting the enzyme 5-alpha reductase, which converts testosterone to dihydrotestosterone (DHT). By reducing DHT levels, it can help slow down or prevent hair loss and reduce prostate size.
  • What are the common dosages of Finasteride used in these trials? The trials used various dosages of Finasteride, including 1 mg tablets for hair loss treatment and 5 mg tablets for prostate-related conditions. Some studies also explored the use of 3 mg doses for bioequivalence testing.
  • Are there any side effects associated with Finasteride? While the trials primarily focused on efficacy and bioequivalence, some studies monitored for adverse events. Common side effects of Finasteride can include decreased libido, erectile dysfunction, and changes in hormone levels. Always consult with a healthcare provider for a complete list of potential side effects.
  • How long do patients typically need to take Finasteride to see results? The duration of treatment varies depending on the condition being treated. For hair loss, it may take several months to a year to see noticeable results. For prostate-related conditions, the effects may be observed sooner. Many of the trials in this review lasted for several months to years to assess long-term efficacy and safety.

Ongoing Clinical Trials on Finasteride

  • Study on How Degarelix and Drug Combination Affect Gut Health in Patients with Prostate Cancer or Benign Prostate Hyperplasia

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

Glossary

  • Bioequivalence: The property of two drug products having the same active ingredient, dosage form, strength, and route of administration to be pharmaceutically equivalent and to have the same rate and extent of absorption when administered under similar conditions.
  • Androgenetic Alopecia: A common form of hair loss in both men and women, also known as male or female pattern baldness, caused by a combination of genetic and hormonal factors.
  • Benign Prostatic Hyperplasia (BPH): A non-cancerous enlargement of the prostate gland that can cause urinary symptoms in older men.
  • Dihydrotestosterone (DHT): A hormone derived from testosterone that plays a role in male pattern baldness and prostate enlargement.
  • Erythrocytosis: An increase in the number of red blood cells in the blood, which can be a side effect of testosterone therapy.
  • Central Serous Chorioretinopathy (CSC): An eye condition characterized by fluid accumulation under the retina, which can cause vision distortion.
  • Optical Coherence Tomography (OCT): A non-invasive imaging technique that uses light waves to take cross-section pictures of the retina.
  • Phototrichogram: A method used to assess hair growth by taking standardized photographs of a specific area of the scalp over time.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Crossover Study: A type of clinical trial where participants receive different treatments in a specific sequence, allowing each participant to serve as their own control.

References

  1. https://clinicaltrials.gov/study/NCT01133444
  2. https://clinicaltrials.gov/study/NCT01133457
  3. https://clinicaltrials.gov/study/NCT01264289
  4. https://clinicaltrials.gov/study/NCT01264302
  5. https://clinicaltrials.gov/study/NCT05611593
  6. https://clinicaltrials.gov/study/NCT00837252
  7. https://clinicaltrials.gov/study/NCT02548117
  8. https://clinicaltrials.gov/study/NCT01227993
  9. https://clinicaltrials.gov/study/NCT00871247
  10. https://clinicaltrials.gov/study/NCT00870480